脱矿骨基质市场- 按产品类型（凝胶、油灰、海绵、纤维、糊剂）、应用（牙科、颅颌面、关节重建、脊柱融合）、最终用途（医院、专科诊所） - 全球预测， 2024 年- 2032 年

由于全球骨科疾病发生率不断上升，脱矿骨基质市场预计从 2024 年到 2032 年将以 4.9% 的复合CAGR扩张。人口老化、运动相关损伤和退化性骨疾病等因素增加了骨科手术对脱矿骨基质 (DBM) 产品的需求。 DBM 能够促进骨折、脊椎融合和关节重建中的骨癒合和再生，因此越来越受到外科医生的青睐。

此外，外科医生依靠 DBM 提供的骨诱导特性来促进成功的骨修復。随着骨科疾病盛行率的上升，对 DBM 的需求不断增加，从而为行业参与者提供了潜在的成长机会。例如，2023 年10 月，总部位于尔湾的Biogennix 是一家骨生物学公司，致力于为骨融合手术创造、製造和销售独特的骨移植材料，推出了完全由脱矿质皮质纤维製成的新型OsteoSPAN纤维基质。

脱矿骨基质产业分为产品类型、应用、最终用途和地区。

根据产品类型，预计 2024 年至 2032 年光纤领域的市场规模CAGR将达到 4.6%。 DBM 纤维在各种骨科应用（例如脊椎融合和骨移植手术）中提供增强的操控性和多功能性。它们还提供骨再生的支架，促进新骨的形成以及与周围组织的整合。外科医生更喜欢 DBM 纤维，因为它易于使用并且能够适应复杂的解剖结构。此外，这些纤维具有加速癒合过程的卓越骨诱导特性，也推动了它们的采用。

在应用方面，牙科领域的脱矿骨基质市场预计在2024年至2032年间将出现5.1%的增长率。这是由于DBM因其促进骨再生和提高种植成功率的能力而在牙科手术中广泛使用费率。牙科手术，例如齿槽保留、上颚窦提升和牙周手术，受益于 DBM 的骨诱导特性，有助于骨癒合和整合。对植牙和口腔手术的需求不断增长，加上牙齿疾病的盛行率上升，正在推动 DBM 在牙科领域的使用。

考虑到区域格局，亚太地区脱矿骨基质产业将在 2023 年产生可观的收入，并预计到 2032 年CAGR为5.5%。这一增长是由于人口众多且老龄化，加上该地区骨科和牙科疾病发病率的增加。地区。不断增长的医疗支出正在为改善医疗基础设施让路。此外，政府促进先进医疗技术和研发投资的措施也有助于区域产业的扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 骨科疾病的发生率上升
    • 脊椎融合和牙科手术数量不断增加
    • 随着人口的增长而增加患者基础
    • 去矿骨基质领域的技术进展
  • 产业陷阱与挑战
    • 去矿骨基质成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

• 主要趋势
• 凝胶
• 油灰
• 海绵
• 纤维
• 贴上
• 其他产品类型

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

• 主要趋势
• 牙科应用
• 颅颚面
• 关节重建
• 脊椎融合术
• 其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 专科诊所
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Exactech, Inc.
• Halma plc
• Hans Biomed Corporation Ltd
• Institut Straumann AG
• Johnson & Johnson
• Medtronic plc
• RTI Surgical, Inc.
• Seaspine Holdings Corporation
• Stryker Corporation
• Xtant Medical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.

Demineralized Bone Matrix Market is poised to expand at 4.9% CAGR from 2024 to 2032 due to the rising incidence of orthopedic conditions globally. Factors, such as increasing aging population, sports-related injuries, and degenerative bone diseases are contributing to the demand for demineralized bone matrix (DBM) products in orthopedic surgeries. The ability of DBM to promote bone healing and regeneration in fractures, spinal fusions, and joint reconstructions is surging its preference among surgeons.

Additionally, surgeons rely on the osteoinductive properties offered by DBM to facilitate successful bone repair. With the rising prevalence of orthopedic disorders, the demand for DBM is rising, thereby providing potential growth opportunities to the industry players. For instance, in October 2023, Irvine-based Biogennix, an osteobiologics firm that creates, manufactures, and markets unique bone graft materials for bone fusion surgeries, introduced the new OsteoSPAN Fiber Matrix, made entirely of demineralized cortical fibers.

The demineralized bone matrix industry is segmented into product type, application, end-use, and region.

Based on product type, the market size from the fiber segment is anticipated to record 4.6% CAGR from 2024-2032. DBM fibers offer enhanced handling and versatility in various orthopedic applications, such as spinal fusions and bone grafting procedures. They also provide a scaffold for bone regeneration, promoting new bone formation and integration with surrounding tissues. Surgeons prefer DBM fibers for their ease of use and ability to conform to complex anatomies. Additionally, the superior osteoinductive properties of these fibers to accelerate the healing process is fueling their adoption.

In terms of application, the demineralized bone matrix market from the dental segment is projected to witness 5.1% growth rate between 2024 and 2032. This is owing to the widespread use of DBM in dental surgeries for its ability to promote bone regeneration and enhance implant success rates. Dental procedures, such as socket preservation, sinus lifts, and periodontal surgeries benefit from the osteoinductive properties of DBM, aiding in bone healing and integration. The growing demand for dental implants and oral surgeries coupled with the rising prevalence of dental disorders is boosting the use of DBM in the dental field.

Given the regional landscape, the Asia Pacific demineralized bone matrix industry generated considerable revenue in 2023 and is set to exhibit 5.5% CAGR through 2032. The growth is due to the large and aging population, coupled with increasing incidences of orthopedic and dental conditions in the region. The rising healthcare expenditure is making way for improving healthcare infrastructure. Moreover, government initiatives for promoting advanced medical technologies and investments in R&D are contributing to the regional industry expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of orthopedic disorders
    • 3.2.1.2 Increasing number of spinal fusion and dental surgeries
    • 3.2.1.3 Increasing patient base with growing population
    • 3.2.1.4 Technological advancements in the field of demineralized bone matrix
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of demineralized bone matrix
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Gel
• 5.3 Putty
• 5.4 Sponge
• 5.5 Fiber
• 5.6 Paste
• 5.7 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Dental applications
• 6.3 Craniomaxillofacial
• 6.4 Joint reconstruction
• 6.5 Spinal fusion
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Specialty clinics
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Exactech, Inc.
• 9.2 Halma plc
• 9.3 Hans Biomed Corporation Ltd
• 9.4 Institut Straumann AG
• 9.5 Johnson & Johnson
• 9.6 Medtronic plc
• 9.7 RTI Surgical, Inc.
• 9.8 Seaspine Holdings Corporation
• 9.9 Stryker Corporation
• 9.10 Xtant Medical Holdings, Inc.
• 9.11 Zimmer Biomet Holdings, Inc.